A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.
NS Jahchan, JT Dudley, PK Mazur, N Flores… - Cancer …, 2013 - europepmc.org
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug-repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug-repositioning bioinformatics approach querying a …
[HTML][HTML] A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors
NS Jahchan, JT Dudley, PK Mazur, N Flores… - Cancer …, 2013 - ncbi.nlm.nih.gov
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug-repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug-repositioning bioinformatics approach querying a …
[PDF][PDF] A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - researchgate.net
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
NS Jahchan, JT Dudley, PK Mazur, N Flores… - Cancer …, 2013 - escholarship.org
UnlabelledSmall cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung
cancer with high mortality. We used a systematic drug repositioning bioinformatics approach …
cancer with high mortality. We used a systematic drug repositioning bioinformatics approach …
A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - Cancer …, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Small cell lung cancer (SCLC) is an
aggressive neuroendocrine subtype of lung cancer with high mortality. We used a …
aggressive neuroendocrine subtype of lung cancer with high mortality. We used a …
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors
NS Jahchan, JT Dudley, PK Mazur… - Cancer …, 2013 - mdanderson.elsevierpure.com
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
[PDF][PDF] A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - academia.edu
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors
NS Jahchan, JT Dudley, PK Mazur… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
[PDF][PDF] A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - Citeseer
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …